Conference Chairmen Keynote Speakers
Chris Baldwin
Chief Commercial Officer, Exopharm Ltd. | 
Dolores Di Vizio
Professor, Cedars Sinai Medical Center | 
Raghu Kalluri
Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center | 
Fatah Kashanchi
Professor and Director of Research, Lab of Molecular Virology, George Mason University | 
My Mahoney
Professor and Vice Chair, Thomas Jefferson University | 
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Alissa Weaver
Cornelius Vanderbilt Professor of Cell and Developmental Biology, Vanderbilt University Medical Center |
OverviewSelectBIO EV-based Diagnostics, Delivery & Therapeutics 2021 Conference, February 25-26, 2021 Virtually Implemented in the US Eastern Time Zone brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: - Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
- Exosome/EV Engineering -- Engineered Exosomes for Delivery
- Drug Delivery via Engineered Vesicles
- Exosomes/EV-based Therapeutics Development
- Exosomes/EVs-derived from Stem Cells and their Role in Regenerative Medicine
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date. Conference Presentations and Content Organization - EV-based Diagnostics, Delivery and Therapeutics 2021
- Circulating Biomarkers 2021
The Conference is Virtually Run and Powered by Zoom.If you have not yet received your Zoom login credentials from SelectBIO, please contact Jeff Fan at J.Fan@selectbio.com
Agenda Topics- Engineered Exosomes and Extracellular Vesicles (EVs) for Drug Delivery
- Engineering EVs as Biologic Drugs and Vaccines
- Ex Vivo Production of Large Quantities of EVs for Therapeutics: Challenges and Opportunities
- Exosomes-based Diagnostics/Liquid Biopsy Development
- Diagnostics Markers Carried by Exosomes
- Liquid Biopsy Enabled by Analyzing Exosome Biomarker Cargo
- Exosomes/EVs-based Drug Delivery Approaches
- Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
- Stem Cell-based EVs for Regenerative Medicine
- Mesenchymal Stem Cells (MSCs): EVs as a Mediator of Cell Therapy?
- The Intersection of Exosomes and Viruses
- Is there a Deep Connection Between Exosomes/EVs and Animal Viruses?
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Distinguished FacultyJohnathon Anderson, Assistant Professor, University of California-Davis
Zoltan Varga, Biological Nanochemistry Research Group, Research Centre for Natural Sciences (RCNS)
John Nolan, CEO, Cellarcus Biosciences, Inc.
Rachel DeRita, Director, Extracellular Vesicle Core Facility, University of Pennsylvania School of Veterinary medicine
Leonid Margolis, Head, Section of Intercellular Interactions, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, NIH
Jack Keene, James B. Duke Professor, Duke University Medical Center
Aurelio Lorico, Professor of Pathology, Touro University Nevada School of Medicine
|
| Corporate Sponsors | Web Sponsors | Offical Journal Partner | Networking |
| |  |  |
|
